On July 11, 2023, Efrat Assa Kunik informed the Orgenesis Inc. of her decision to resign as Chief Development Officer of the Company to pursue other opportunities. Ms. Assa-Kunik will remain with the Company until she completes her transition of duties, through August 8, 2023. Ms. Assa-Kunikâs decision to resign did not result from any disagreement with the Company, its management or its board of directors on any matter, whether related to the Companyâs operations, policies, practices or otherwise.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 USD | +0.99% | +8.33% | +3.85% |
20/05 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | North American Morning Briefing : Powell Comments, -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+3.85% | 17.55M | |
-6.54% | 178B | |
-0.32% | 107B | |
-2.05% | 67.04B | |
-7.14% | 47.23B | |
+12.24% | 44.62B | |
+9.53% | 42.5B | |
+15.37% | 29.99B | |
+14.50% | 25.22B | |
-6.64% | 24.14B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. Announces Efrat Assa Kunik to Resign as Chief Development Officer, Effective August 8, 2023